Alan Escher
Dr. Alan Escher, PhD, is Executive Vice President of Technology Development at SEKRIS Biomedical, Inc. (Redlands, California), a biotechnology company that develops innovative DNA immunotherapies for the treatment of inflammatory disorders like type 1 diabetes and organ transplant rejection. Dr. Escher was previously Associate Professor and Associate Director of the Center for Transplant Immunology Research at the Loma Linda University School of Medicine in Loma Linda, California. His training includes a PhD in Microbiology from Cornell University and a post-doctoral fellowship at the University of Alberta.